The Knowledge Group Has Scheduled a Live Webcast on The Hatch-Waxman Act: Recent Amendments and Developments
Summary
Because of its significant impact on both brand and generic drug companies, it is imperative for the pharma industry to keep abreast of the latest developments in Hatch-Waxman Act: amendments, as well as potential changes in the year ahead.Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they bring the audience to a road beyond the basics of the Hatch-Waxman Act.This Live webcast will discuss the following key topics: § The Hatch-Waxman Act: Overview and Legal Framework § Latest Developments § The Abbreviated New Drug Application (ANDA) Process § Latest Developments in ANDA Litigation § Recent FDA Applications § The Hatch-Waxman Act in 2018 – An Outlook Speakers/Faculty Panel: Mark T. Deming Shareholder Polsinelli Martin B. Pavane Vice Chair, Intellectual Property Department, Co-Chair, Hatch-Waxman & Biologics Litigation Cozen OConnor Joseph Reisman Partner Knobbe Martens Olson & Bear LLP For an updated list of the faculty panel, please visit: https://www.theknowledgegroup.org/webcasts/healthcare/health-law-healthcare/the-hatch-waxman-act About The Knowledge Group/The Knowledge Congress Live Webcast Series The Knowledge Group brings together the worlds leading authorities and industry participants through informative two-hour webcasts that study the impact of changing regulations and help businesses succeed through proper regulatory compliance.By requiring the abbreviated new drug application (ANDA) process, Hatch-Waxman regulates the approval of a "bioequivalent" generic drug while protecting the patent rights of an existing brand drug.Because of its significant impact on both brand and generic drug companies, it is imperative for the pharma industry to keep abreast of the latest developments in Hatch-Waxman Act: amendments, as well as potential changes in the year ahead.Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they bring the audience to a road beyond the basics of the Hatch-Waxman Act.Speakers will also provide the audience with practical strategies when it comes to ANDA litigation.This Live webcast will discuss the following key topics:§ The Hatch-Waxman Act: Overview and Legal Framework§ Latest Developments§ The Abbreviated New Drug Application (ANDA) Process§ Latest Developments in ANDA Litigation§ Recent FDA Applications§ The Hatch-Waxman Act in 2018 – An OutlookSpeakers/Faculty Panel:Mark T. DemingShareholderPolsinelliMartin B. PavaneVice Chair, Intellectual Property Department, Co-Chair, Hatch-Waxman & Biologics LitigationCozen OConnorJoseph ReismanPartnerKnobbe Martens Olson & Bear LLPFor an updated list of the faculty panel, please visit: https://www.theknowledgegroup.org/webcasts/healthcare/health-law-healthcare/the-hatch-waxman-actAbout The Knowledge Group/The Knowledge Congress Live Webcast SeriesThe Knowledge Group brings together the worlds leading authorities and industry participants through informative two-hour webcasts that study the impact of changing regulations and help businesses succeed through proper regulatory compliance.Visit http://theknowledgegroup.org/ for further information and inquiry.